Competitive NMDA receptor antagonists and spinal-cord ischemia

Area of Science:

• Neuroscience
• Pharmacology
• Ischemic injury research

Background:

• Ischemic neuronal death involves excitatory amino acid (EAA) release, primarily mediated by N-methyl-D-aspartate (NMDA) receptors.
• Blocking NMDA receptors prior to ischemic events may reduce neuronal damage.

Purpose of the Study:

• To investigate the neuroprotective effects of two competitive NMDA receptor antagonists, CPP and CGS, during spinal cord ischemia in a rat model.
• To determine if these antagonists offer protection against varying durations of ischemic insult.

Main Methods:

• Male Sprague-Dawley rats received intrathecal administration of saline, CPP, or CGS.
• Rats were subjected to balloon occlusion of the thoracic aorta to induce spinal cord ischemia.
• Acute protocol: determined the aortic occlusion time (AOT) causing paraplegia in 50% of animals (P50).
• Chronic study: rats underwent a 12-min occlusion, followed by daily neurological scoring for 28 days and histological cord examination.

Main Results:

• In the acute study, the P50 for CGS and CPP was significantly longer than for saline, indicating protection against shorter ischemic durations.
• In the chronic study, no significant differences in neurological or histological scores were observed between the saline, CPP, and CGS groups after 12-min occlusion.

Conclusions:

• NMDA receptor blockade with CPP or CGS may provide partial neuroprotection for ischemic durations approaching the P50 threshold.
• These antagonists are not effective in preventing neuronal damage in cases of more protracted spinal cord ischemia.